New Treatment Options for Advanced Melanoma

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this video from Memorial Sloan-Kettering Cancer Center, several experts discuss new treatments for melanoma, including vemurafenib (Zelboraf), which targets the activity of mutated BRAF genes found in approximately half of melanoma tumors, and ipilimumab (Yervoy), which uses the immune system to fight melanoma. The participants in the discussion include Paul Chapman, MD, an oncologist and melanoma expert, and Charlotte Ariyan, MD, PhD, a surgeon specializing in surgical oncology who conducts research into immunotherapy for cancer.

Related Articles
The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.
Adults aged 50 years or older who feel comfortable about aging are more likely to seek preventive health care services.
The FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of Novartis’ first-in-class secukinumab therapy for moderate-to-severe plaque psoriasis.
In the pediatric hospital setting, pharmacists most frequently perform drug therapy changes on the cancer ward.
Latest Issues
$auto_registration$